Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuxi Kaifu Pharmaceutical is a China-based pharmaceutical company focused on the development, manufacturing, and commercialization of finished dosage forms and active pharmaceutical ingredients (APIs). The company operates modern production facilities that comply with Good Manufacturing Practice (GMP) standards to produce a variety of oral solid preparations and chemical raw materials. Its product portfolio primarily addresses therapeutic areas such as gastroenterology, cardiovascular health, and central nervous system disorders. Wuxi Kaifu Pharmaceutical serves both domestic and international markets, positioning itself as a reliable supplier of high-quality generic medications and specialized pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuxi Kaifu Pharmaceutical.